SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Arrowhead Pharma Reports Dosing Of First Patient In AROAAT2002 Open Label Phase 2 Study Of ARO-AAT For Treatment Of Alpha-1 Liver Disease

Benzinga · -